Mahindra Lifespace Share Gains As OMRON Healthcare To Setup Plant At Origins
Shares of Mahindra Lifespace Developers Ltd. rose on Monday after it said that Japan-based OMRON Healthcare Co. will start operations at the company's IGBC platinum pre-certified industrial cluster, Origins by Mahindra.
OMRON Healthcare's factory will be built over 6.02 acres and will be manufacturing blood pressure monitors, mainly for supply in the domestic market.
Origins by Mahindra has been developed by Mahindra Industrial Park Chennai Ltd., which is a joint venture between Mahindra World City Developers Ltd. and Sumitomo Corporation.
Shares of the company advanced 4.01% intraday, before paring gains and trading at a 1.82% high as of 10.08 a.m. This compares to a 0.47% rise in the benchmark Nifty 50. The stock rose the most since May 31.
The total traded volume so far in the day stood at 4.3 times its 30-day average. The relative strength index stands at 74, suggesting the stock may be overbought.
All eight analysts tracking the company maintained a 'buy' rating, according to Bloomberg data. The average 12-month consensus price target implies an upside of 7.5%.
-
Midterm Rally Lasted A Day. The Hard Reality Of A Divided US May Last Two Years | Opinion
Between a contested AI boom, a debt ceiling that arrives in 2027 and a president with every incentive to act alone, the next two years may prove more volatile than the first day's rally suggests.
-
Blue Wave Will Derail the AI Trade but Won't Dismantle the AI Era | Unhedged Position
The Democrats' sweep of the US Congress will see politics collide with economic forces both over the long and short term.
-
It's Time To Take The GST Council's Bet On Trust Global
Payment records can prove India's services exports, and clear, proportionate rules can bring foreign digital sellers into the tax net.
-
Opinion | India at 38: From Innovation Overperformer to Innovation Powerhouse
India now has 453 VC-backed deep science startups, 18 of them late-stage, after 117 percent growth since 2020. Laurus Labs, at USD 9.3 billion, is the most valuable deep science company in any middle-income economy outside China.
-
Navigating Energy Crossroads: S Jaishankar's Call For Diversified Supply Chains At G20 Ministerial Meeting
As geopolitical fault lines continue to test maritime trade routes and commodity flows, Jaishankar's message remains pertinent: true economic resilience requires open markets, protected transit lines, and a genuine commitment to multilateral cooperation rather than coercion.
-
Indians Are Travelling, But Not Every Journey Is A Holiday | The Week In Whys
Pilgrims, patients and working women are the real travellers, and the system hasn't quite caught up with them.
-
Getting To Work Costs Women More | The Reason Why
It is not just about women paying more than men. It is about women paying much more in cities than in villages.
-
AI Bias In Investing Cannot Be Eliminated, But It Can Be Governed
Framing is a particularly important example as identical financial information presented in terms of gains rather than losses can lead an LLM to reach a different assessment.
-
Joining The Dots | Dark Skies, Steady Diya: Why Hope Holds This Diwali
With war, a weak rupee and foreign outflows weighing on sentiment, policymakers at the NDTV World Summit and market veterans at NDTV Profit Ignite: Diwali Edition offered the same advice: stay invested and filter out the noise.
